Eye Health Pipeline

[Download Pipeline](/content/science-innovation/human-health-innovation/clinical-pipeline/pdf/human-pharma-clinical-pipeline "Download Pipeline PDF"/index.html)

[Interactive view](/content/science-innovation/human-health-innovation/clinical-pipeline?view=interactive "Switch to the interactive view"/index.html)

About our Eye Health efforts

The ambition to prevent vision loss in people at risk, and preserve or restore vision in those with retinal diseases, is at the core of our R&D activities. Our extensive knowledge and insights from other therapeutic areas enable us to tackle the multifactorial pathophysiology of retinal diseases. Areas of focus include wet age-related macular degeneration, diabetic retinopathy and geographic atrophy.

Additional links

• [Retinal Health Research](/content/science-innovation/human-health-innovation/science-focus/eye-health-research "Visit Retinal Health Research page"/index.html)
• [Retinal Health: A Clear Vision](/content/human-health/eye-health/clear-vision "Visit Retinal Health Clear Vision page"/index.html)
• For Healthcare Professionals
• [For Patients](/content/human-health/eye-health "Visit Eye Health page"/index.html)
• OpnMe - Molecule Library

Phase 2 Projects

Eye Health

• Diabetic macular edema
  Oral vascular modulator
  BI 1815368
  Read more about BI 1815368

Eye Health

• Diabetic retinopathy
  Sema3A antibody
  BI 764524
  Read more about BI 764524

Eye Health

• Geographic atrophy
  Phospholipid modulator
  BI 1584862
  Read more about BI 1584862

Eye Health

• Geographic atrophy
  Antibody fragment
  BI 771716
  Read more about BI 771716

Filter Classification

• Anchored in external partnership or acquisition
• Breakthrough Therapy/Device Designation granted
• Fast Track Designation granted by the U.S. Food and Drug Administration
• Being investigated in combination with other therapies